FDA 483 - BlendHouse LLC - February 17, 2023

The provided document outlines the legal basis and purpose of an FDA Form 483, rather than detailing a specific inspection report from a company with specific inspection dates. Under FD&C Act Section 704(b) (21 U.S.C. 374(b)), this form is issued by an FDA officer at the conclusion of an inspection to report "objectionable conditions and practices." These conditions typically indicate that a product—whether food, drug, device, or cosmetic—either consists of "filthy, putrid, or decomposed substance" or has been prepared, packed, or held under "insanitary conditions" that could lead to contamination or render it injurious to health. The regulatory framework for this report is rooted in the FD&C Act. The FDA 483 serves to notify the inspected firm of observed deficiencies, aiming to assist companies in ensuring compliance with FDA acts and regulations. Upon issuance, the inspecting officer provides the report to the firm's owner or agent, and a copy is promptly sent to the Secretary of the FDA. The implicit required action for the company is to address these reported conditions to rectify any non-compliance and prevent potential health risks or product adulteration.